Biosimilars: A Decade In Review
Duncan Emerton Looks Back Over A Decade Of Experiences With Biosimilars
Executive Summary
The past decade has been transformative for the global biosimilars industry as regulators, developers, physicians, patients and payers from all over the world have grappled with complex, and often market-shaping, issues.